|
Market Cap (24-May) $66,720,148 (584th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 696,012 |
Shortsold (16-Jan) 98 (0.00%) (641st) |
|
52w High $0.099 |
52w Low $0.021 |
P/E 25.97 |
EPS 0 |
ACW released this announcement to the ASX on 8 October 2021, 11:44. The announcement is not marked as price sensitive, and is 44 page(s) in length and 776.33kb in size.
You can view all announcements from ACW and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACW was 0.012% short sold according to ASIC data. It was ranked the 601st most shorted stock on the ASX. It remains ranked 641st as of the latest reported data (16 January 2025).
| Other Recent Announcements from ACW | |
|---|---|
| ACW CEO presentation on emerging oral Alzheimers therapies | 21 June 2023, 8:50 |
| ACW CEO & CMO present at BIO International Convention | 5 June 2023, 9:06 |
| ACW AD trial amendment and Clinical Science Forum slides | 24 May 2023, 8:20 |
| Letter to Shareholders & Notice of Annual General Meeting | 8 October 2021, 11:44 |
| Date of AGM and Closing Date for Director Nominations | 22 September 2021, 17:58 |
| Application for quotation of securities - ACW | 16 September 2021, 16:15 |
| Appendix 4G | 30 August 2021, 16:37 |
You must be logged in to post a reply.
Actinogen Medical 